These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 455216)

  • 1. Continuous intravenous arabinosyl cytosine infusions delivered by a new portable infusion system.
    Bottino J; McCredie KB; Ho DW; Freireich EJ; Buckles R; Herbst S; Lawson M
    Cancer; 1979 Jun; 43(6):2197-201. PubMed ID: 455216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of the pharmacokinetics of high-dose ara-C by its metabolite, high ara-U in patients with acute leukemia.
    Capizzi RL; Yang JL; Cheng E; Bjornsson T; Sahasrabudhe D; Tan RS; Cheng YC
    J Clin Oncol; 1983 Dec; 1(12):763-71. PubMed ID: 6668493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of low-dose cytosine arabinoside.
    Spriggs D; Griffin J; Wisch J; Kufe D
    Blood; 1985 May; 65(5):1087-9. PubMed ID: 3995167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I study of intermittent continuous infusion high dose cytosine arabinoside for acute leukemia.
    Stone RM; Spriggs DR; Dhawan RK; Arthur KA; Mayer RJ; Kufe DW
    Leukemia; 1990 Dec; 4(12):843-7. PubMed ID: 2243507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic studies of continuous infusion of arabinosylcytosine by liquid infusion system.
    Ho DH; Brown NS; Benvenuto J; McCredie KB; Buckels D; Freireich EJ
    Clin Pharmacol Ther; 1977 Sep; 22(3):371-4. PubMed ID: 268246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of continuous intravenous and subcutaneous infusions of cytosine arabinoside.
    Weinstein HJ; Griffin TW; Feeney J; Cohen HJ; Propper RD; Sallan SE
    Blood; 1982 Jun; 59(6):1351-3. PubMed ID: 7082832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose ara-C administered by continuous subcutaneous infusion: a pharmacologic evaluation.
    Spriggs DR; Sokal JE; Griffin J; Kufe DW
    Cancer Drug Deliv; 1986; 3(3):211-6. PubMed ID: 3779605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy.
    Gandhi V; Estey E; Keating MJ; Plunkett W
    J Clin Oncol; 1993 Jan; 11(1):116-24. PubMed ID: 8418222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of a continuous infusion of high-dose ara-C in conjunction with a fixed dose of 2'-deoxycytidine (IND 28108) in patients with refractory leukemia: an interim report.
    Grant S; Baker M; Bhalla K
    Leukemia; 1993 Dec; 7(12):1933-8. PubMed ID: 8255091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ara-C in plasma and ara-CTP in leukemic cells after subcutaneous injection and continuous intravenous infusion of ara-C in patients with acute nonlymphoblastic leukemia.
    Liliemark JO; Gahrton G; Paul CY; Peterson CO
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):167-71. PubMed ID: 3589691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose mercaptopurine followed by intermediate-dose cytarabine in relapsed acute leukemia.
    Lockhart S; Plunkett W; Jeha S; Ramirez I; Zipf T; Cork A; Pinkel D
    J Clin Oncol; 1994 Mar; 12(3):587-95. PubMed ID: 8120558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic effects of a combination of intermediate-dose cytosine arabinoside, adriamycin and vincristine in relapsed acute leukemia].
    Takahashi I; Yorimitsu S; Inagaki T; Sekito N; Hayashi N; Nishimura M; Aoyama S; Nakada H; Ohmoto E; Uchida K
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):485-9. PubMed ID: 3813576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical effect of low-dose Ara-C in patients with refractory acute nonlymphocytic leukemia and myelodysplastic syndrome].
    Yoshida M; Tsunoda S; Akutsu M; Furukawa Y; Takeda K; Akashi M; Komatsu N; Muroi K; Ikeda K; Ohsaka A
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1057-62. PubMed ID: 3566302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology and toxicity of high-dose cytarabine by 72-hour continuous infusion.
    Donehower RC; Karp JE; Burke PJ
    Cancer Treat Rep; 1986 Sep; 70(9):1059-65. PubMed ID: 3461882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of a portable infusion pump in ambulatory patients receiving continuous infusions of anticancer drugs.
    Dorr RT; Trinca CE; Griffith K; Dombrowsky PL; Salmon SE
    Cancer Treat Rep; 1979 Feb; 63(2):211-3. PubMed ID: 87271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous infusion high-dose cytosine arabinoside in refractory childhood leukemia.
    Ochs J; Sinkule JA; Danks MK; Look AT; Bowman WP; Rivera G
    J Clin Oncol; 1984 Oct; 2(10):1092-7. PubMed ID: 6593435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-specific dose rate for continuous infusion high-dose cytarabine in relapsed acute myelogenous leukemia.
    Heinemann V; Estey E; Keating MJ; Plunkett W
    J Clin Oncol; 1989 May; 7(5):622-8. PubMed ID: 2709090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-dose cytarabine treatment in acute leukemias and leukemic meningiosis: clinical aspects and pharmacokinetics].
    Nowrousian MR; Seeber S; Miller AA; Anders C; Ohl S; Schmidt CG
    Onkologie; 1985 Feb; 8(1):26-32. PubMed ID: 3885117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of refractory/relapsed acute leukemia with cytosine arabinoside plus tetrahydrouridine (an inhibitor of cytidine deaminase)--a pilot study.
    Kreis W; Budman DR; Chan K; Allen SL; Schulman P; Lichtman S; Weiselberg L; Schuster M; Freeman J; Akerman S
    Leukemia; 1991 Nov; 5(11):991-8. PubMed ID: 1961042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: implications for a continuous infusion schedule.
    Seymour JF; Huang P; Plunkett W; Gandhi V
    Clin Cancer Res; 1996 Apr; 2(4):653-8. PubMed ID: 9816215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.